查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1733193

全球青光眼手術設備市場規模：依產品類型、手術類型、最終用戶、區域範圍和預測

Global Glaucoma Surgery Devices Market Size By Product, By Surgery Type, By End-Users, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

青光眼手術設備市場規模及預測

2024年青光眼手術設備市場規模為 11.3386億美元，預計到2032年將達到 70.0606億美元，2026年至2032年的年複合成長率為 28.20%。

  • 青光眼手術設備是用於青光眼手術治療的專用設備，青光眼是全球不可逆失明的主要原因。
  • 這些設備用於各種手術，包括小梁切除術、管分流手術和微創青光眼手術（MIGS）。
  • 這些設備的應用對於降低眼壓（IOP）和保護青光眼患者的視力非常重要。
  • 人口老化和青光眼盛行率的上升推動了對青光眼治療創新有效解決方案的需求。
  • 這一趨勢導致了技術和手術技術的重大進步，提高了青光眼手術的有效性和安全性。
  • 因此，預計，在持續研發的支持下，這些設備在已開發市場和新興市場的採用率都將顯著增加。

全球青光眼手術器材市場動態

影響全球青光眼手術設備市場的主要市場動態是：

主要市場促進因素

  • 青光眼的盛行率：青光眼在世界各地的盛行率很高，據報導有數百萬人受到這種慢性疾病的影響。預計患者數量的增加將大幅增加對青光眼手術設備的需求。根據系統性系統綜述和統合分析，預計2020年全球青光眼患者人數為 7,600萬人，到2040年將增加到 1.118億人。
  • 人口老化：老化社會導致與老齡化相關的眼科疾病（包括青光眼）的發生率增加。預計老年人口的增加將增加對有效外科手術介入的需求。
  • 技術進步：青光眼手術設備領域見證越來越多的技術進步，提高安全性和有效性。這些技術創新有望透過為患者提供更好的治療選擇來刺激市場成長。
  • 醫療保健支出：醫療保健支出增加，尤其是在已開發地區，這可能會推動對先進醫療設備的投資。隨著醫院和診所尋求提高其手術能力，這一趨勢預計將推動青光眼手術設備的採用。

主要問題

  • 設備成本高：青光眼手術設備的高成本被認為是主要限制因素。如此高的成本預計將限制一些醫療保健提供者獲得醫療服務的機會，尤其是在新興市場。
  • 償付問題：許多醫療保健系統面臨償付問題，並且對青光眼手術的償付範圍不一致。這些挑戰預計將阻礙青光眼手術設備市場的成長，因為醫院可能會猶豫是否在沒有償付確定性的情況下投資先進技術。
  • 缺乏熟練的專家：缺乏接受過先進青光眼手術技術訓練的熟練專家。預計這種短缺將阻礙創新青光眼手術設備在臨床實踐中的有效採用和利用。
  • 患者意識：患者對青光眼及其治療方法的認知通常有限，尤其是在開發中地區。據估計，缺乏這種認知會阻礙對青光眼手術設備的需求，因為患者可能不會及時尋求治療。

主要趨勢

  • 對微創手術的需求：患者和醫療保健提供者對微創手術的需求都很高。預計這一趨勢將導致專為微創手術設計的青光眼手術設備的採用率增加，有助於縮短恢復時間。
  • 數位科技的整合：據報道，青光眼管理領域人工智慧和遠端醫療等數位技術的整合日益加強。這些進步有望提高診斷準確性和手術計劃，推動相關手術設備市場的發展。
  • 注重個人化醫療：青光眼治療越來越注重個人化醫療。預計這一趨勢將推動定製手術干預和設備的發展，以滿足個別患者的需求。
  • 製造商和醫療保健提供者之間的合作：看到青光眼手術設備製造商和醫療保健提供者之間的合作日益增多。這將促進知識和資源的共用，並有望促進創新產品的開發和手術效果的改善。

目錄

第1章 全球青光眼手術器械市場介紹

  • 市場介紹
  • 研究範圍
  • 先決條件

第2章 執行摘要

第3章 已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章 青光眼手術器械全球市場展望

  • 概述
  • 市場動態
    • 促進因素
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章 全球青光眼手術器械市場（依產品）

  • 概述
  • 青光眼引流裝置
  • 青光眼雷射設備
  • 植入和支架

第6章 全球青光眼手術器械市場（依手術類型）

  • 概述
  • 微創青光眼手術
  • 傳統青光眼手術

第7章 全球青光眼手術器械市場（依最終用戶）

  • 概述
  • 眼科醫院和眼科診所
  • 門診手術中心
  • 門診手術中心

第8章 全球青光眼手術器材市場（依地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 其他
    • 拉丁美洲
    • 中東和非洲

第9章 全球青光眼手術設備市場的競爭格局

  • 概述
  • 各公司市場排名
  • 重點發展策略

第10章 公司簡介

  • Carl Zeiss Meditec AG
  • Abbott Laboratories
  • Iridex Corporation
  • Alcon, Inc.
  • Glaukos Corporation
  • ASICO
  • Katalyst Surgical
  • Ziemer Ophthalmic Systems AG
  • Lumenis Ltd.

第11章 附錄

  • 相關調查
簡介目錄
Product Code: 33171

Glaucoma Surgery Devices Market Size And Forecast

Glaucoma Surgery Devices Market size was valued at USD 1133.86 Million in 2024 and is projected to reach USD 7006.06 Million by 2032, growing at a CAGR of 28.20% from 2026 to 2032.

  • Glaucoma surgery devices are specialized instruments used in the surgical management of glaucoma, a leading cause of irreversible blindness worldwide.
  • These devices are utilized in various procedures, including trabeculectomy, tube shunt surgery, and minimally invasive glaucoma surgery (MIGS).
  • The application of these devices is essential in lowering intraocular pressure (IOP) and preserving vision in patients diagnosed with glaucoma.
  • A growing demand for innovative and effective solutions in glaucoma treatment is being witnessed, driven by an aging population and a rising prevalence of the disease.
  • This trend has led to significant advancements in technology and surgical techniques, enhancing the effectiveness and safety of glaucoma surgeries.
  • Consequently, a notable increase in the adoption of these devices is anticipated in both developed and emerging markets, supported by ongoing research and development efforts.

Global Glaucoma Surgery Devices Market Dynamics

The key market dynamics that are shaping the global glaucoma surgery devices market include:

Key Market Drivers:

  • Prevalence of Glaucoma: A high prevalence of glaucoma is being reported globally, with millions of individuals affected by this chronic condition. It is anticipated that this growing patient population will drive the demand for glaucoma surgery devices significantly. According to a systematic review and meta-analysis, the number of people with glaucoma worldwide was estimated to be 76 million in 2020, with projections suggesting this number will increase to 111.8 million by 2040.
  • Aging Population: A growing aging population is being observed, leading to an increased incidence of age-related eye diseases, including glaucoma. The rising number of elderly individuals is expected to contribute to the demand for effective surgical interventions.
  • Advancements In Technology: Increasing advancements in technology are being made in the field of glaucoma surgery devices, enhancing their safety and efficacy. These innovations are projected to stimulate market growth by providing better treatment options for patients.
  • Healthcare Expenditure: A rising healthcare expenditure is being noted, particularly in developed regions, which is likely to facilitate investment in advanced medical devices. This trend is expected to support the adoption of glaucoma surgery devices as hospitals and clinics seek to upgrade their surgical capabilities.

Key Challenges:

  • High Costs of Devices: The high costs associated with glaucoma surgery devices are being identified as a significant restraint. It is anticipated that these elevated expenses will limit access for some healthcare providers, especially in emerging markets.
  • Reimbursement Issues: Reimbursement issues are being faced by many healthcare systems, where coverage for glaucoma surgeries is not consistently provided. It is expected that these challenges will impede the growth of the glaucoma surgery devices market as hospitals may hesitate to invest in advanced technologies without assured reimbursement.
  • Lack of Skilled Professionals: A lack of skilled professionals trained in advanced glaucoma surgical techniques is being noted. This shortage is projected to restrain the effective implementation and utilization of innovative glaucoma surgery devices in clinical settings.
  • Patient Awareness: Patient awareness regarding glaucoma and its surgical treatment options is often limited, particularly in developing regions. It is estimated that this lack of awareness will hamper the demand for glaucoma surgery devices, as individuals may not seek timely treatment.

Key Trends:

  • Demand for Minimally Invasive Procedures: A high demand for minimally invasive procedures is being observed among both patients and healthcare providers. It is anticipated that this trend will lead to the increased adoption of glaucoma surgery devices specifically designed for less invasive techniques, promoting quicker recovery times.
  • Integration of Digital Technologies: Growing integration of digital technologies, such as artificial intelligence and telemedicine, is being reported in the glaucoma management sector. These advancements are expected to enhance the diagnostic accuracy and surgical planning, thereby driving the market for associated surgical devices.
  • Focus on Personalized Medicine: An increasing focus on personalized medicine is being recognized within the glaucoma treatment landscape. It is projected that this trend will encourage the development of tailored surgical interventions and devices that cater to individual patient needs.
  • Collaboration Between Manufacturers and Healthcare Providers: Rising collaboration between manufacturers of glaucoma surgery devices and healthcare providers is being noted. It is likely to facilitate the sharing of knowledge and resources, resulting in the development of innovative products and improved surgical outcomes.

Global Glaucoma Surgery Devices Market Regional Analysis

Here is a more detailed regional analysis of the global glaucoma surgery devices market:

North America:

  • North America is expected to dominate the glaucoma surgery devices market due to advanced healthcare infrastructure and high prevalence rates of glaucoma.
  • According to the National Eye Institute, more than 3 million Americans had glaucoma in 2020, a number projected to reach 4.2 million by 2030.
  • The United States is anticipated to hold the largest share, driven by the presence of key market players and a strong emphasis on research and development.
  • Increasing healthcare expenditures and a growing elderly population are projected to further contribute to market growth in the region.
  • In Canada, a rising awareness of eye health is being observed, leading to more frequent screenings and diagnoses of glaucoma.
  • It is estimated that advancements in minimally invasive surgical techniques will enhance the adoption of glaucoma surgery devices.
  • The presence of a robust healthcare system is likely to support the ongoing growth of this market segment.

Europe:

  • Europe is anticipated to experience significant growth in the glaucoma surgery devices market, attributed to the increasing aging population and high incidence of glaucoma across the region.
  • According to Eurostat, the percentage of people aged 65 and over in the EU-27 is projected to increase from 20.3% in 2019 to 29.4% by 2050. The European Glaucoma Society reports that the prevalence of glaucoma in Europe is approximately 2.93% in people over 40, rising to 5.1% in those over 75.
  • Countries such as Germany and France are projected to lead the market, driven by a combination of advanced healthcare facilities and government initiatives aimed at improving eye care services.
  • Rising investments in innovative surgical technologies are expected to foster market expansion in these nations.
  • The United Kingdom is also likely to contribute to regional growth through the implementation of public health campaigns focusing on glaucoma awareness.
  • Enhanced access to advanced surgical procedures is projected to boost the adoption of glaucoma surgery devices.
  • Additionally, collaborations between healthcare providers and device manufacturers are anticipated to facilitate the development of new and effective treatment options.

Global Glaucoma Surgery Devices Market: Segmentation Analysis

The Global Glaucoma Surgery Devices Market is Segmented on the basis of Product, Surgery Type, End-Users, And Geography.

Glaucoma Surgery Devices Market, By Product

  • Glaucoma Drainage Devices
  • Glaucoma Laser Devices
  • Implants And Stents

Based on Product, the market is bifurcated into Glaucoma Drainage Devices, Glaucoma Laser Devices, and Implants And Stents. Glaucoma drainage devices are expected to hold the largest share of the glaucoma surgery devices market due to their effectiveness in managing intraocular pressure (IOP) in patients with refractory glaucoma. Increasing prevalence rates of glaucoma and the growing elderly population are anticipated to drive demand for these devices significantly. The success of drainage devices in reducing IOP, especially in patients who have not responded well to conventional treatments, is projected to enhance their adoption in clinical settings.

Glaucoma Surgery Devices Market, By Surgery Type

  • Conventional Glaucoma Surgeries
  • Minimally Invasive Glaucoma Surgeries

Based on Surgery Type, the global Glaucoma Surgery Devices Market is divided into Conventional Glaucoma Surgeries and Minimally Invasive Glaucoma Surgeries. The segment of conventional glaucoma surgeries is expected to hold the largest share of the glaucoma surgery devices market. This segment includes established procedures such as trabeculectomy and tube shunt surgeries, which have been widely utilized for many years. A high prevalence of advanced glaucoma cases requiring surgical intervention is anticipated to drive demand in this category. The effectiveness of these traditional surgical methods in significantly lowering intraocular pressure is projected to enhance their continued use in clinical practice.

Glaucoma Surgery Devices Market, By End-Users

  • Eye Hospitals And Ophthalmology Clinics
  • Ambulatory Surgical Centers
  • Outpatient Surgical Centers

Based on End-Users, the market is segmented into Eye Hospitals And Ophthalmology Clinics, Ambulatory Surgical Centers, and Outpatient Surgical Centers. Eye hospitals and ophthalmology clinics are expected to hold the largest share of the glaucoma surgery devices market due to the increasing demand for specialized eye care services. These facilities are anticipated to benefit from a growing prevalence of glaucoma and a rising awareness among the population regarding eye health. The availability of advanced surgical technologies within these settings is likely to enhance treatment outcomes, thereby attracting more patients seeking glaucoma management.

Glaucoma Surgery Devices Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
  • On the basis of Geography, the global glaucoma surgery devices market is classified into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region is expected to be a rapidly growing market for glaucoma surgery devices, primarily due to the rising prevalence of glaucoma among aging populations. Countries such as China and India are projected to witness significant increases in demand, driven by a combination of population growth and urbanization. Investments in healthcare infrastructure are likely to support the market's expansion in these countries.

Key Players

The "Global Glaucoma Surgery Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Carl Zeiss Meditec AG, Abbott Laboratories, Iridex Corporation, Alcon, Inc., Glaukos Corporation, ASICO, Katalyst Surgical, Nidek Co., Ltd., Ziemer Ophthalmic Systems AG, and Lumenis Ltd. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

  • Glaucoma Surgery Devices Market Recent Developments
  • In July 2022, a strategic partnership for the treatment of glaucoma was announced by iSTAR Medical and AbbVie. This collaboration afforded AbbVie the opportunity to significantly diversify its line of eye care products and offer glaucoma patients more treatment options.
  • In November 2021, SMART Solutions by Alcon, a digital platform specifically created for ophthalmology, was demonstrated at the American Academy of Ophthalmology (AAO) 2021 annual conference by Alcon, the world leader in eye care committed to supporting people in seeing brilliantly. This innovative platform is reinforced by Alcon's leadership in the clinic-to-operating room, integration with image-guided technologies, and cloud-based planning

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL GLAUCOMA SURGERY DEVICES MARKET

  • 1.1 Introduction of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL GLAUCOMA SURGERY DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Glaucoma Drainage Devices
  • 5.3 Glaucoma Laser Devices
  • 5.4 Implants & Stents

6 GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY SURGERY TYPE

  • 6.1 Overview
  • 6.2 Minimally Invasive Glaucoma Surgeries
  • 6.3 Conventional Glaucoma Surgeries

7 GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY END-USERS

  • 7.1 Overview
  • 7.2 Eye Hospitals & Ophthalmology Clinics
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Outpatient Surgical Centers

8 GLOBAL GLAUCOMA SURGERY DEVICES MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East & Africa

9 GLOBAL GLAUCOMA SURGERY DEVICES MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Carl Zeiss Meditec AG
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Abbott Laboratories
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Iridex Corporation
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Alcon, Inc.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Glaukos Corporation
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 ASICO
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Katalyst Surgical
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Ziemer Ophthalmic Systems AG
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Lumenis Ltd.
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments

11 Appendix

  • 11.1 Related Research"